Recital 8, Regulation (EU) 2019/168

In forcesince 31 Jan 2019

Taking into account that the approval periods of the active substances benfluralin, fluazinam, flutolanil and mepiquat expire on 28 February 2019, this Regulation should enter into force as soon as possible.